de.mpg.escidoc.pubman.appbase.FacesBean
Deutsch
 
Hilfe Wegweiser Impressum Kontakt Einloggen
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Vortrag

Elucidation of the Influenza A Virus Glycosylation Patterns with Respect to Vaccine Production Down to the Lower Zeptomolar Range

MPG-Autoren
http://pubman.mpdl.mpg.de/cone/persons/resource/persons86442

Rapp,  E.
Physical and Chemical Foundations of Process Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86475

Schwarzer,  J.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86448

Reichl,  U.
Otto-von-Guericke-Universität Magdeburg;
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

Externe Ressourcen
Es sind keine Externen Ressourcen verfügbar
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Rapp, E., Schwarzer, J., & Reichl, U. (2007). Elucidation of the Influenza A Virus Glycosylation Patterns with Respect to Vaccine Production Down to the Lower Zeptomolar Range. Talk presented at 21st International Symposium on MicroScale Bioseparations (MSB). Vancouver, BC, Canada. 2007-01-14 - 2007-01-18.


Zitierlink: http://hdl.handle.net/11858/00-001M-0000-0013-9855-A
Zusammenfassung
The ability of monitoring and thereby controlling the glycosylation pattern of viral membrane-proteins during the vaccine production process, is a prerequisite for yield enhancement in vaccine production and to ensure sufficient immune-response after vaccination. The glycosylation pattern of viral glycoproteins can be affected by virus strain, host cell glycosylation machinery, cultivation conditions and via incipient degradation of the glycosylation during virus inactivation and downstream processing. The presented approach allows the characterization of N-glycosylation patterns, shown exemplarily on hemagglutinin of influenza A/PR/8/34(H1N1) virus, produced in MDCK-cells. The procedure includes: virus purification and concentration directly from cell-culture supernatant, followed by preparation, separation and identification of viral (glyco-)proteins and their N-glycan pools, utilizing: g-force-step-gradient-centrifugation, SDS-PAGE, enzymatical cleavage, fluorescent labeling, CGE-LIF (employing a DNA-sequenzer) and MALDI-TOF MS. The N-glycans are analyzed in two stages: glycome fingerprints and structural identification. Generation of fingerprints with CGE-LIF, enables LODs down to the lower zeptomolar range. Additional structural information are obtained, spiking the samples with a series of N-glycan standards, measured with CGE-LIF and MALDI-TOF MS. This proceeding enables monitoring of N-glycosylation patterns of relevant glycoproteins during major steps of up- and downstream processing in influenza virus vaccine production.